doi : 10.1097/ICU.0000000000000965
Volume 34(4) pgs. v-vi,273-360 July 2023
Lee, Jimmy K.
Arboleda, Nathan; Yi, Joseph; Kang, Joann J.
doi : 10.1097/ICU.0000000000000958
Although refractive surgery is one of the most commonly performed ophthalmic procedures, there is a relative paucity of literature on residency and fellowship refractive surgery education
Ong, Lauren F. a,*; Oh, Alyce b,*; Yi, Joseph K. c; Gu, Joshua S. d; Marvasti, Amir H. b; Nguyen, Betsy B. b; Tran, Dan B. b; Lee, Jimmy K. b
doi : 10.1097/ICU.0000000000000956
The purpose of this article is to provide a review of the literature on refractive lens exchange and present a retrospective analysis of 55 patients who underwent refractive lens exchange at a single practice.
Hein, J. Christian a; Tauber, Jenna b; Shrivastava, Anurag b
doi : 10.1097/ICU.0000000000000954
The aim of this study was to provide an update on perioperative considerations in the evaluation and management of patients undergoing primary corneal and intraocular refractive procedures who are at risk for progressive glaucomatous optic neuropathy.
Onishi, Alex C. a; Lee-Choi, Calisa b; Marvasti, Amir H. a,b
doi : 10.1097/ICU.0000000000000957
Currently, the most commonly performed corneal refractive surgery is laser-assisted in-situ keratomileusis (LASIK). Customized forms of LASIK have been developed, which have allowed for improved outcomes and the enhanced correction of higher order aberrations (HOAs).
Kaufman, Ron a,b; Jun, Albert S. a
doi : 10.1097/ICU.0000000000000964
With limited access of more than half the world's population to corneal transplantation, regenerative medicine may represent a promising alternative.
Tran, Tu M.; Hou, Joshua H.
doi : 10.1097/ICU.0000000000000961
To discuss bioengineered tissue-cellular products for treatment of corneal diseases that are currently in clinical use. These include tissue-cellular products that have received regulatory approval, are being used off-label in clinical practice, or are in active use in clinical trials.
Hicks, Patrice M. a; Armstrong, Mikhayla L. b; Woodward, Maria A. a,c
doi : 10.1097/ICU.0000000000000960
To achieve health equity in eye health and vision care, social determinants of health (SDoH) and the associated social risk factors must be addressed.
Tran, Lillian T.; Li, Jennifer Y.
doi : 10.1097/ICU.0000000000000962
Cell-based therapies are an exciting new frontier in managing corneal diseases. The introduction of these novel therapies may provide new alternatives to corneal transplantation and decrease the dependence on donor corneal tissue.
Hafezi, Farhad a,b,c,d,e; Torres-Netto, Emilio A. a,b,f; Hillen, Mark a
doi : 10.1097/ICU.0000000000000967
The aim of this study was to summarize the recent developments in corneal cross-linking (CXL) and its indications, including corneal ectasias, refractive surgery and infectious keratitis.
Northey, Luke C. a,b; Moloney, Gregory a,b
doi : 10.1097/ICU.0000000000000963
To summarize recent literature on Descemet's stripping only (DSO) in management of endothelial disease with particular focus on Fuchs endothelial corneal dystrophy (FECD).
Douglas, Vivian Paraskevi a; Douglas, Konstantinos A.A. a; Torun, Nurhan b
doi : 10.1097/ICU.0000000000000955
Optical coherence tomography angiography (OCTA) is a novel, noninvasive imaging technique, which provides depth resolved visualization of microvasculature of the retina and choroid.
Do you want to add Medilib to your home screen?